Investigating the folding dynamics of NS2B protein of Zika virus.
Disorder protein
Flavivirus
MD simulation
NS2B protein
Zika virus
Journal
Virology
ISSN: 1096-0341
Titre abrégé: Virology
Pays: United States
ID NLM: 0110674
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
received:
16
12
2022
revised:
16
04
2023
accepted:
28
04
2023
medline:
2
6
2023
pubmed:
22
5
2023
entrez:
21
5
2023
Statut:
ppublish
Résumé
NS2B protein of the Zika virus acts as a co-factor for NS3 protease and also involves in remodeling NS3 protease structure. Therefore, we investigated the overall dynamics of NS2B protein. We find surprising similarities between selected flavivirus NS2B model structures predicted from Alphafold2. Further, the simulated ZIKV NS2B protein structure shows a disordered cytosolic domain (residues 45-95) as a part of a full-length protein. Since only the cytosolic domain of NS2B is sufficient for the protease activity, we also investigated the conformational dynamics of only ZIKV NS2B cytosolic domain (residues 49-95) in the presence of TFE, SDS, Ficoll, and PEG using simulation and spectroscopy. The presence of TFE induces α-helix in NS2B cytosolic domain (residues 49-95). On the other hand, the presence of SDS, ficoll, and PEG does not induce secondary structural change. This dynamics study could have implications for some unknown folds of the NS2B protein.
Identifiants
pubmed: 37210794
pii: S0042-6822(23)00094-6
doi: 10.1016/j.virol.2023.04.012
pii:
doi:
Substances chimiques
Viral Nonstructural Proteins
0
Ficoll
25702-74-3
Peptide Hydrolases
EC 3.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24-36Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.